Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway

ABSTRACT:

SUBMITTER: Ma L 

PROVIDER: S-EPMC10777026 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature